A value-based analysis of the systematic use of dapagliflozin in patients with heart failure

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Professor Hector Bueno

National Centre for Cardiovascular Research (CNIC), Madrid (Spain)

12 More presentations in this session

Presentation thumbnail

Discussant - Public health and cardiovascular disease

Presentation thumbnail

Economic burden of elevated lipoprotein(a) in secondary prevention atherosclerotic cardiovascular disease cohort from England

Mrs M. Caido (London, GB)

Abstract Slides Video

Presentation thumbnail

Chronic disease trajectory network and Monte Carlo simulation in Chinese population

Doctor J. Fei (Beijing, CN)

Presentation thumbnail

Multiscale entropy, a novel non-linear method, better reflected the detrimental impact of ambient air pollution on 24-hour heart rate variability than linear method or detrended fluctuation analysis

Doctor C. Huang (Taipei, TW)

Abstract Slides Video

Presentation thumbnail

The first year of generic NOACs: implications for patients and the healthcare system

Doctor R. Barbosa Sousa (Lisbon, PT)

Abstract Slides Video

Access the full session

Session thumbnail

New perspectives in cardiology (1) - Public health and cardiovascular disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Reduction of heart failure hospitalization-related healthcare costs for transthyretin amyloid cardiomyopathy patients on treatment

Congress Presentation

Trends of health care costs of heart failure during implementation of SGLT2 inhibitors: Data from Finnish nationwide registers

Congress Session

Using big data to drive cardiovascular innovations

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources